Evidence map›Paper›PMID 42036676›Full record

ArticleCell & bioscience2026

SIAH2-EPHB6 axis enhances filopodia formation in hepatocellular carcinoma cells by regulating RHOF.

Qinghe Hu, Kai Wu, Zhiyi Liu, Jiawei Xu, Weichao Yang, Nan Xia, Tianqi Hou, Yun Zhu, Kuan Cao, Hengliang Shi and 2 more

Abstract read
In one paragraph

Article in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qinghe Hu *Technology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Kai WuTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Zhiyi Liu *Technology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Jiawei XuTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Weichao YangTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Nan XiaTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Tianqi HouTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yun ZhuTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Kuan CaoTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Hengliang ShiTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. shl@xzhmu.edu.cn.
Yi HeTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. 100002007043@xzhmu.edu.cn.
Bin ZhangTechnology Innovation and Public Service Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. zhangbin@xzhmu.edu.cn.

Funding

Advanced Program of The Affiliated Hospital of Xuzhou Medical University PYJH2024204Advanced Program of The Affiliated Hospital of Xuzhou Medical University PYJH2025305Basic Research Program of Jiangsu Province BK20231166Construction Project of High Level Hospital of Jiangsu Province GSPJS202401Construction Project of High Level Hospital of Jiangsu Province GSPJS202502Introduce top clinical medical expert team project of the Health Commission of Xuzhou 2025TD03Jiangsu Postgraduate Research Innovation Program KYCX25_3278Jiangsu Postgraduate Research Innovation Program KYCX25_3317Jiangsu Provincial Medical Key Discipline ZDXK202224National Natural Science Foundation of China Project 82573050Natural Science Project of The Affiliated Hospital of Xuzhou Medical University 2024ZL11Xuzhou Institute of Technology KC23152
6 · The paper itself

Abstract

Seven in absentia homologue 2 (SIAH2) has been shown to contribute to the progression of various human tumors, including hepatocellular carcinoma (HCC). However, the precise mechanisms by which SIAH2 promotes HCC cell migration remain to be fully elucidated. In this study, we demonstrate that SIAH2 accelerates the invasion and migration of HCC cells by promoting K48-linked polyubiquitination and degradation of EPH receptor B6 (EPHB6). Notably, the invasion and migration of HCC cells regulated by the SIAH2-EPHB6 axis in association with enhanced filopodia formation, a critical early step in cell motility. Furthermore, our findings indicate that the SIAH2-EPHB6 axis promotes filopodia formation in HCC cells by modulating Ras homolog family member F (RHOF). Finally, we investigated the expression correlations among SIAH2, EPHB6, and RHOF using clinical tissue specimens. In summary, SIAH2 accelerates K48-linked polyubiquitination and degradation of EPHB6 to regulate filopodia formation in HCC cells.

Indexed as

EPHB6Filopodia formationHCCPolyubiquitinationRHOFSIAH2

Identifiers

PMID42036676
PMCPMC13262507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.